<DOC>
	<DOCNO>NCT01580605</DOCNO>
	<brief_summary>This study conduct Europe . The aim study extract data French National Registry hold information patient initiated growth hormone therapy objective describe patient receive growth hormone therapy , assess efficacy safety somatropin ( Norditropin® SimpleXx® ) evaluate treatment compliance .</brief_summary>
	<brief_title>French National Registry Adults With Growth Hormone Deficiency Treated With Somatropin</brief_title>
	<detailed_description />
	<mesh_term>Endocrine System Diseases</mesh_term>
	<mesh_term>Dwarfism , Pituitary</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Adult growth hormone deficiency Treated Norditropin® SimpleXx ( somatropin )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>